Name: 글로벌 시장 동향
SKU: MD1397
Availability: InStock

보고서 요약(국문)

개요
동맥류 코일링 및 색전술 기기 시장은 2023년 YY백만 달러에 도달했으며, 2024년부터 2031년까지 연평균 성장률(CAGR) YY%로 성장하여 2031년에는 YY백만 달러에 이를 것으로 예상됩니다.
전 세계 동맥류 코일링 및 색전술 기기는 뇌동맥류 치료에 사용됩니다. 동맥류는 혈관벽이 약해지거나 부풀어 오른 부분을 말합니다. 동맥류를 코일링하거나 색전술 기기를 혈관에 삽입하여 파열을 방지함으로써 심각한 부상이나 사망을 예방합니다.
시장 성장의 주요 동력으로는 고령화, 흡연, 유전적 소인, 고혈압 유병률 증가, 그리고 색전술 기기 개발의 발전 등이 있습니다. 코일 특성, 보조 장치 및 중재 시술의 기술 발전으로 인해 혈관내 코일 색전술은 파열 및 비파열 동맥류 모두에 대해 효과적이고 성공적인 치료 옵션으로 자리 잡았으며, 장기적인 동맥류 폐쇄율을 높이고 있습니다.
시장은 지속적인 혁신과 첨단 장비 도입으로 특징지어지며, 복잡한 동맥류를 효과적으로 치료하는 데 중점을 두고 있습니다. 풍선 보조 코일 색전술 및 스텐트 보조 코일 색전술과 같은 기술은 코일 충전 밀도를 높이고 폐쇄율을 개선하며 동맥류 재발률을 낮추기 위해 개발되었으며, 특히 목이 넓거나 크고 거대한 동맥류에 효과적입니다.
시장 동향: 동인
두개내 동맥류(IA) 및 관련 위험의 증가
시장 성장을 이끄는 주요 요인은 두개내 동맥류 및 관련 위험의 발생률 증가입니다. 이 시장에서 뇌동맥류 파열은 매우 높은 이환율과 사망률을 보입니다. 2023년 4월 NCBI에 발표된 연구에 따르면, 환자의 약 25%가 파열 후 24시간 이내에 사망하고, 50%는 이후 3개월 이내에 사망합니다.
추가적인 동맥류가 발생할 확률은 20%입니다. 미국인 1,000명 중 약 20명은 일생 동안 파열되지 않은 뇌동맥류를 경험하게 됩니다. 뇌동맥류 위험을 증가시키는 요인으로는 흡연, 고혈압, 장기간의 음주 등이 있습니다.
뇌동맥류 재단(Brain Aneurysm Foundation)의 2024년 자료에 따르면, 미국에서는 680만 명이 파열되지 않은 뇌동맥류를 앓고 있습니다. 10만 명당 약 8,000~10,000명이 뇌동맥류 파열을 경험합니다. 미국에서는 약 3만 명이 뇌동맥류의 영향을 받으며, 전 세계적으로는 이 질환으로 인해 매년 5백만 명 이상이 사망합니다.
또한, 주요 시장 참여 기업들의 기술 발전이 시장 확장에 크게 기여하고 있습니다. 2021년 7월, 테루모 의료(Terumo Medical Corporation)는 AZUR 혈관 플러그를 출시했습니다. 테루모의 색전술은 말초 혈관의 혈류를 완전히 차단하거나 조절하는 것을 목표로 합니다.
제한 요인
높은 치료 비용, 복잡한 시술, 엄격한 규제 요건, 합병증 위험, 숙련된 전문가 부족 등의 여러 요인이 시장 성장을 저해할 것으로 예상됩니다.
이 보고서에 대한 자세한 내용은 샘플을 요청하십시오.
세분화 분석
동맥류 코일링 및 색전술 기기 시장은 제품 유형, 적용 분야, 재료, 최종 사용자 및 지역별로 세분화됩니다.

색전 코일 부문은 동맥류 코일링 및 색전술 기기 시장 점유율의 약 49.3%를 차지했습니다.
색전 코일 부문은 예측 기간 동안 가장 큰 시장 점유율을 유지할 것으로 예상됩니다. 색전 코일로 알려진 이 가늘고 금속성 와이어는 동맥류 내부에 정밀하게 배치되어 혈액 응고를 유도합니다. 이 과정은 병변 부위를 주변 순환계로부터 차단하여 뇌동맥류 치료를 돕고 잠재적으로 치명적인 파열을 예방합니다.
또한, 뇌동맥류 발생률 증가와 색전술과 같은 최소 침습 시술의 이점에 대한 이해도 증가는 이 시장 부문의 확장에 기여하고 있습니다.
업계 주요 업체들이 개발한 신경계 질환 치료용 제품의 기술 발전은 시장 성장을 견인하고 있습니다. 예를 들어, 2023년 1월에는 뇌의 가장 바깥층에 발생하는 만성 경막하혈종(CSDH) 치료에 사용될 수 있는 IMPASS 색전 코일 장치가 생체 내 연구에서 중뇌막동맥(MMA) 색전술에 성공적으로 사용되었습니다. 이 정보는 Fludix Medical Technology, Inc.에서 공개했습니다.
또한, 주요 시장 참여 업체들은 혁신적인 제품 출시에 집중하고 있습니다. 예를 들어, 2021년 3월에는 Shape Memory Medicals의 IMPEDE-FX 색전 플러그가 일본 의약품의료기기종합기구(PMDA)의 승인을 받았습니다. IMPEDE-FX 색전 플러그는 말초 혈관의 혈류 속도를 저해하거나 차단하는 데 사용됩니다.
지역별 분석
북미는 시장 점유율의 약 42.4%를 차지했습니다.
북미 지역은 예측 기간 동안 가장 큰 시장 점유율을 유지할 것으로 예상됩니다. 북미 시장 성장을 견인하는 주요 요인으로는 특히 미국의 유리한 의료비 상환 정책, 연구 개발 투자 확대, 신경외과 의사들의 색전술 기기 채택 증가, 뇌혈관 질환 유병률 증가, 최소 침습 수술의 인기 상승, 그리고 의료비 상승 등이 있습니다.
또한, 2021년 4월 미국 식품의약국(FDA)은 메드트로닉(Medtronic PLC)의 쉴드(Shield) 기술이 적용된 파이프라인 플렉스 색전술 기기를 승인했는데, 이 기기는 주로 뇌동맥류 치료에 사용됩니다. 쉴드 기술은 소재로 인한 혈전 형성 위험을 감소시켜 혈류 전환 장치의 효과를 향상시킵니다.
더불어, 2021년 3월 인스틸라(Instylla, Inc.)는 핵심적인 엠브레이브 하이드로겔 시스템(HES)을 이용한 고혈관성 종양 치료를 위한 글로벌 무작위 임상 시험에 초기 환자 등록을 시작했다고 발표했습니다.

시장 세분화
제품 유형별
• 색전 코일
• 동맥류 클립
• 혈류 전환 장치
• 액체 색전제
• 풍선 및 스텐트 보조 코일
• 기타
적용 분야별
• 종양 및 뇌암
• 뇌동정맥 기형
• 허혈성 뇌졸중
• 뇌동맥류
• 뇌부종
• 비뇨기과
• 말초혈관 질환
• 기타
재질별
• 티타늄
• 코발트
• 기타
최종 사용자별
• 병원
• 외래 수술 센터
• 클리닉
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 스페인
o 이탈리아
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 남미 한국
• 아시아 태평양 지역 (기타)
• 중동 및 아프리카
경쟁 환경
뇌동맥류 코일 색전술 및 색전술 기기 시장의 주요 글로벌 업체로는 Acandis GmbH, Johnson & Johnson Services, Inc., Medtronic, Penumbra, Inc., Stryker, Terumo Corporation, MicroPort Scientific Corporation, Abbott, W. L. Gore & Associates, Inc. 및 KANEKA CORPORATION 등이 있습니다.
주요 개발 사항
 2023년 7월 31일, MicroVention, Inc.는 WEB-IT 5년 모니터링 기술을 출시하여 다양한 WEB 뇌동맥류 색전술 시스템의 유형과 크기에 적용 범위를 넓혔습니다. WEB 기기는 동맥류 주머니 내부의 뇌동맥류를 치료하도록 설계되어 혈류를 차단하는 동시에 MicroVention의 MicroBraid 기술을 사용하여 동맥류 목 부분을 밀봉하고 돔 부분을 보호합니다. 이러한 발전은 의료진과 환자들이 신경혈관 색전술을 선택하도록 유도하고 있습니다.

 2022년 6월 1일, 메드트로닉은 인도에서 뇌동맥류 치료를 위한 쉴드 기술이 적용된 파이프라인 밴티지 색전술 기기를 출시했습니다. 이 기술은 전달 시스템과 임플란트 모두에 향상된 설계 기능을 갖춘 새로운 혈류 전환 장치입니다.

 2022년 12월 6일, 스트라이커는 인도에 새로운 연구 개발 센터를 개설했습니다. 이 시설의 주요 목표는 뇌졸중 치료에 특화된 첨단 신경혈관 기기 개발을 가속화하는 것이었습니다. 이 센터 개설을 통해 스트라이커는 연구 개발 시설을 강화하고, 숙련된 인력을 확보하고, 글로벌 시장 진출 범위를 확장하고, 글로벌 시장에 대한 귀중한 통찰력을 얻을 수 있었습니다.

보고서 구매 이유:

• 제품 유형, 재료, 최종 사용자 및 지역별 동맥류 코일링 및 색전술 기기 시장 세분화를 시각화하고 주요 상업 자산 및 업체들을 파악하기 위함입니다.

• 트렌드 분석 및 공동 개발을 통해 상업적 기회를 파악합니다.
• 모든 세그먼트를 포함한 동맥류 코일링 및 색전술 기기 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품을 모두 포함하는 제품 맵핑 자료를 Excel 파일로 제공합니다.
동맥류 코일링 및 색전술 기기 시장 보고서는 약 70개의 표, 70개의 그림, 180페이지 분량입니다.
주요 고객 (2024년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
The aneurysm coiling and embolization devices market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.
The global aneurysm coiling and embolization devices used in treating brain aneurysms. An aneurysm can be defined as a weakening or bulging part of the blood vessle wall. In order to coil or plug an aneurysm, coiling and embolization devices are inserted in the blood vessel. It prevent it from bursting which could cause serious injury or even death.
The main driving forces dehind the market growth invole an aging population, smoking, genetic predisposition, and the increasing prevalence of hypertension, as well as advancements in the development of embolization devices. Owing to technological progress in coil characteristics, auxiliary devices and interventional procedures, endovascular coiling has become a viable and successful therapeutic option for both ruptured and unruptured aneurysms, leading a higher long term aneurysm occlusion rates.
The market is characterized by ongoing innovation and the introduction of advanced devices, focusing on effectively treating complex aneurysm. Techniques like ballon-assisted coiling and stent-assisted coiling have been developed to enchance coil packing density, improve obliteration rates, and decrease aneurysm recurrence rates, particularly for wide-necked, large, and gaint aneurysms.
Market Dynamics: Drivers
Rising prevalence of intracranial aneurysms (IAs) & associated risks
The key factor driving the market growth is the rising incidence of intracranial aneurysms & associated risks would drive the market. In this market, cerebral aneurysm ruptures are having very high morbidity and mortality. A study published in NCBI, in April 2023, nearly 25% are dead within the first 24 hours, and 50 % will die within the next three months.
There's a 20% chance of additional aneurysms developing. Approximately 20 out of 1,000 Americans will face an unruptured IA at some point in their lives. Factors increasing the risk of IAs include smoking, high blood pressure, and long-term alcohol consumption.
According to Brain Aneurysm Foundation data from 2024, in U.S., 6.8 miilion people have suffering from unruptured brain aneurysm. Out of 100,000 individuals, approximately 8,000 to 10,000 people encounter brain ruptures. In the U.S., brain aneurysms impact around 30,000 people, while globally, this condition leads to over 5 million annual fatalities.
Moreover, substantial progress in technology by prominent market players significantly contributes to market expansion. In July 2021, Terumo Medical Corporation launch the AZUR Vascular Plug. Terumo’s embolozation methods targets the complete regulation or cessation of bloof flow in peripheral vascular.
Restraints
Several factors, including high cost of the treatments, complexity associated with procedures, strict regulatory requirements, risk of complications, and a lack of skilled professionals are expected to hamper the market growth.
For more details on this report - Request for Sample
Segment Analysis
The aneurysm coiling and embolization devices market is segmented based on product type, application, material, end-user and region.
The embolic coils segment accounted for approximately 49.3% of the aneurysm coiling and embolization devices market share
The embolic coils segment is expected to hold the largest market share over the forecast period. These thin, metallic wires, knows as embolic coils, are meticulously placed with in aneurysms to stimulate blood clotting. This process ioslates the afflicted region from the broader circulatory system, aiding in the treatment of brain aneurysms and preventing potentially fatal ruptures.
Furthermore, the rising occurance of cerebral aneurysms and the growing understanding of the adavntages offered by minimally invasive procedures, such as embolization, contribute to the expansion of this market segment.
The technological advancements in the product designed for the treatment of neurological developed by the industry's major players drive the growth of the market. For instance, in January 2023, the IMPASS embolic coil devices, which may be utilized to treat chronic subdural hematomas (CSDH) on the outermost layer of the brain, has been successfully employed in in-vivo studies to embolize the middle meningeal artery (MMA). This information was made public by Fludix Medical Technology, Inc.
Furthermore, major market participants are concentrating on introducing innovative products.For instance, in March 2021, Shape Memory Medicals IMPEDE-FX embolization plug received from Japan’s Pharmaceuticals and Medical devices Agency. It is recommended to impede or lower the rate of blood flow in the peripheral vasculature using impede embolization plugs.
Geographical Analysis
North America accounted for approximately 42.4% of the market share
North America region is expected to hold the largest market share over the forecast period. The key factors driving the growth of the North American market compare favorable reimbursement policies, especially in the U.S., availability of R&D investments, increasing adoption of embolization devices by neurosurgeons, and rising prevalence of cerebrovascular illnesses, the growing popularity of minimally invasive surgical procedures, and rising healthcare costs are driving the market growth in this region.
Moreover, in April 2021, the U.S. Food and Drug Administration (FDA) approved the pipeline flex embolization device with the shield technology of Medtronic PLC, which was indicated primarily for a brain aneurysm. Shiled technology enhances the flow diverter device by decreasing thrombogenicity caused due to the material.
Furthermore, in March 2021, Instylla, Inc. confirmed the enrollment of the initial patients in the global randomized clinical trial for the treatment of hypervascular tumors using the pivotal embrace hydrogel system (HES).
Market Segmentation
By Product Type
• Embolic Coils
• Aneurysm clips
• Flow Diversion Device
• Liquid Embolic Agents
• Balloon and stent-assisted coils
• Others
By Application
• Tumor and Brain Cancer
• Brain Arteriovenous Malformations
• Ischemic Stroke
• Brain Aneurysm
• Cerebral Edema
• Urology
• Peripheral Vascular Disease
• Others
By Material
• Titanium
• Cobalt
• Others
By End-User
• Hospitals
• Ambulatory Surgical Units
• Clinics
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o South Korea
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the aneurysm coiling and embolization devices market include Acandis GmbH, Johnson & Johnson Services, Inc., Medtronic, Penumbra, Inc., Stryker, Terumo Corporation, MicroPort Scientific Corporation, Abbott, W. L. Gore & Associates, Inc. and KANEKA CORPORATION among others.
Key Developments
 On July 31, 2023, MicroVention, Inc., launched WEB-IT 5-year monitoring technology, broadening its applicability to various WEB aneurysm embolization system types and sizes. The WEB device is designed to treat brain aneurysms inside the aneurysm sac, disrupting blood flow, while sealing the neck and protecting the dome with MicroVention’s MicroBraid Technology. Such advancements attract healthcare providers and patients to opt for neurovascular embolization.
 On June 1, 2022, Medtronic launched pipeline vantage embolization devices with shield technology in India to treat a brain aneurysm. This technology is a new flow diverter with enhanced design features for both the delivery systems and the implant.
 On December 6, 2022, Stryker inaugurated a new research and development center in India. The main objective of this facility was to accelerate the creation of advanced neurovascular devices, specifically intended for stroke treatment. This inauguration enabled Stryker to enhance its R&D facilities, access a skilled workforce, expand its global reach, and gain valuable insights into the global market.
Why Purchase the Report?
• To visualize the aneurysm coiling and embolization devices market segmentation based on product type, material, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of aneurysm coiling and embolization devices market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.
The aneurysm coiling and embolization devices market report would provide approximately 70 tables, 70 figures, and 180 Pages.
Target Audience 2024
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by Material
3.4. Snippet by End-User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Prevalence of Intracranial Aneurysms (IAs) & Associated Risks
4.1.2. Restraints
4.1.2.1. High Cost of the Treatment
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
8. Embolic Coils *
8.1.1. Introduction
8.1.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.2. Aneurysm clips
8.3. Flow Diversion Device
8.4. Liquid Embolic Agents
8.5. Balloon and stent-assisted coils
8.6. Others
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
10. Tumor and Brain Cancer *
10.1.1. Introduction
10.1.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.2. Brain Arteriovenous Malformations
10.3. Ischemic Stroke
10.4. Brain Aneurysm
10.5. Cerebral Edema
10.6. Urology
10.7. Peripheral Vascular Disease
10.8. Others
11. By Material
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
11.1.2. Market Attractiveness Index, By Material
11.2. Titanium*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Cobalt
11.4. Others
12. By End-User
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.1.2. Market Attractiveness Index, By End-user
12.2. Hospitals*
12.2.1. Introduction
12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
12.3. Ambulatory Surgical Units
12.4. Clinics
13. By Region
13.1. Introduction
13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
13.1.2. Market Attractiveness Index, By Region
13.2. North America
13.2.1. Introduction
13.2.2. Key Region-Specific Dynamics
13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
13.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.2.7.1. U.S.
13.2.7.2. Canada
13.2.7.3. Mexico
13.3. Europe
13.3.1. Introduction
13.3.2. Key Region-Specific Dynamics
13.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
13.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
13.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
13.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.3.7.1. Germany
13.3.7.2. UK
13.3.7.3. France
13.3.7.4. Italy
13.3.7.5. Spain
13.3.7.6. Rest of Europe
13.4. South America
13.4.1. Introduction
13.4.2. Key Region-Specific Dynamics
13.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
13.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
13.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
13.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.4.7.1. Brazil
13.4.7.2. Argentina
13.4.7.3. Rest of South America
13.5. Asia-Pacific
13.5.1. Introduction
13.5.2. Key Region-Specific Dynamics
13.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
13.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
13.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
13.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.5.7.1. China
13.5.7.2. India
13.5.7.3. Japan
13.5.7.4. South Korea
13.5.7.5. Rest of Asia-Pacific
13.6. Middle East and Africa
13.6.1. Introduction
13.6.2. Key Region-Specific Dynamics
13.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
13.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
13.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
14. Competitive Landscape
14.1. Competitive Scenario
14.2. Market Positioning/Share Analysis
14.3. Mergers and Acquisitions Analysis
15. Company Profiles
15.1. Acandis GmbH *
15.1.1. Company Overview
15.1.2. Product Portfolio and Description
15.1.3. Financial Overview
15.1.4. Key Developments
15.2. Johnson & Johnson Services, Inc
15.3. Medtronic
15.4. Penumbra, Inc
15.5. Stryker
15.6. Terumo Corporation
15.7. MicroPort Scientific Corporation
15.8. Abbott
15.9. W. L. Gore & Associates, Inc
15.10. KANEKA CORPORATION
LIST NOT EXHAUSTIVE
16. Appendix
16.1. About Us and Services
16.2. Contact Us

언급된 주요 기업들

Acandis GmbH, 4.	Key Developments, Johnson & Johnson Services, Inc, Medtronic, Penumbra, Inc, Stryker, Terumo Corporation, MicroPort Scientific Corporation, Abbott, W. L. Gore & Associates, Inc, KANEKA CORPORATION

표 목록 (Tables)

List of Tables

Table 1 Global Aneurysm Coiling and Embolization Devices Market Value, By Product, 2023, 2027 & 2031 (US$ Million)

Table 2 Global Aneurysm Coiling and Embolization Devices Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 3 Global Aneurysm Coiling and Embolization Devices Market Value, By Material, 2023, 2027 & 2031 (US$ Million)

Table 4 Global Aneurysm Coiling and Embolization Devices Market Value, By End-user, 2023, 2027 & 2031 (US$ Million)

Table 5 Global Aneurysm Coiling and Embolization Devices Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 6 Global Aneurysm Coiling and Embolization Devices Market Value, By Product, 2023, 2027 & 2031 (US$ Million)

Table 7 Global Aneurysm Coiling and Embolization Devices Market Value, By Product, 2022-2031 (US$ Million)

Table 8 Global Aneurysm Coiling and Embolization Devices Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 9 Global Aneurysm Coiling and Embolization Devices Market Value, By Application, 2022-2031 (US$ Million)

Table 10 Global Aneurysm Coiling and Embolization Devices Market Value, By Material, 2023, 2027 & 2031 (US$ Million)

Table 11 Global Aneurysm Coiling and Embolization Devices Market Value, By Material, 2022-2031 (US$ Million)

Table 12 Global Aneurysm Coiling and Embolization Devices Market Value, By End-user, 2023, 2027 & 2031 (US$ Million)

Table 13 Global Aneurysm Coiling and Embolization Devices Market Value, By End-user, 2022-2031 (US$ Million)

Table 14 Global Aneurysm Coiling and Embolization Devices Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 15 Global Aneurysm Coiling and Embolization Devices Market Value, By Region, 2022-2031 (US$ Million)

Table 16 North America Aneurysm Coiling and Embolization Devices Market Value, By Product, 2022-2031 (US$ Million)

Table 17 North America Aneurysm Coiling and Embolization Devices Market Value, By Application, 2022-2031 (US$ Million)

Table 18 North America Aneurysm Coiling and Embolization Devices Market Value, By Material, 2022-2031 (US$ Million)

Table 19 North America Aneurysm Coiling and Embolization Devices Market Value, By End-user, 2022-2031 (US$ Million)

Table 20 North America Aneurysm Coiling and Embolization Devices Market Value, By Country, 2022-2031 (US$ Million)

Table 21 Asia-Pacific Aneurysm Coiling and Embolization Devices Market Value, By Product, 2022-2031 (US$ Million)

Table 22 Asia-Pacific Aneurysm Coiling and Embolization Devices Market Value, By Application, 2022-2031 (US$ Million)

Table 23 Asia-Pacific Aneurysm Coiling and Embolization Devices Market Value, By Material, 2022-2031 (US$ Million)

Table 24 Asia-Pacific Aneurysm Coiling and Embolization Devices Market Value, By End-user, 2022-2031 (US$ Million)

Table 25 Asia-Pacific Aneurysm Coiling and Embolization Devices Market Value, By Country, 2022-2031 (US$ Million)

Table 26 Europe Aneurysm Coiling and Embolization Devices Market Value, By Product, 2022-2031 (US$ Million)

Table 27 Europe Aneurysm Coiling and Embolization Devices Market Value, By Application, 2022-2031 (US$ Million)

Table 28 Europe Aneurysm Coiling and Embolization Devices Market Value, By Material, 2022-2031 (US$ Million)

Table 29 Europe Aneurysm Coiling and Embolization Devices Market Value, By End-user, 2022-2031 (US$ Million)

Table 30 Europe Aneurysm Coiling and Embolization Devices Market Value, By Country, 2022-2031 (US$ Million)

Table 31 South America Aneurysm Coiling and Embolization Devices Market Value, By Product, 2022-2031 (US$ Million)

Table 32 South America Aneurysm Coiling and Embolization Devices Market Value, By Application, 2022-2031 (US$ Million)

Table 33 South America Aneurysm Coiling and Embolization Devices Market Value, By Material, 2022-2031 (US$ Million)

Table 34 South America Aneurysm Coiling and Embolization Devices Market Value, By End-user, 2022-2031 (US$ Million)

Table 35 South America Aneurysm Coiling and Embolization Devices Market Value, By Country, 2022-2031 (US$ Million)

Table 36 Middle East and Africa Aneurysm Coiling and Embolization Devices Market Value, By Product, 2022-2031 (US$ Million)

Table 37 Middle East and Africa Aneurysm Coiling and Embolization Devices Market Value, By Application, 2022-2031 (US$ Million)

Table 38 Middle East and Africa Aneurysm Coiling and Embolization Devices Market Value, By Material, 2022-2031 (US$ Million)

Table 39 Middle East and Africa Aneurysm Coiling and Embolization Devices Market Value, By End-user, 2022-2031 (US$ Million)

Table 40 Middle East and Africa Aneurysm Coiling and Embolization Devices Market Value, By Country, 2022-2031 (US$ Million)

Table 41 Acandis GmbH: Overview

Table 42 Acandis GmbH: Product Portfolio

Table 43 Acandis GmbH: Key Developments

Table 44 Johnson & Johnson Services, Inc: Overview

Table 45 Johnson & Johnson Services, Inc: Product Portfolio

Table 46 Johnson & Johnson Services, Inc: Key Developments

Table 47 Medtronic.: Overview

Table 48 Medtronic.: Product Portfolio

Table 49 Medtronic.: Key Developments

Table 50 Penumbra, Inc: Overview

Table 51 Penumbra, Inc: Product Portfolio

Table 52 Penumbra, Inc: Key Developments

Table 53 Stryker: Overview

Table 54 Stryker: Product Portfolio

Table 55 Stryker: Key Developments

Table 56 Terumo Corporation: Overview

Table 57 Terumo Corporation: Product Portfolio

Table 58 Terumo Corporation: Key Developments

Table 59 MicroPort Scientific Corporation: Overview

Table 60 MicroPort Scientific Corporation: Product Portfolio

Table 61 MicroPort Scientific Corporation: Key Developments

Table 62 Abbott: Overview

Table 63 Abbott: Product Portfolio

Table 64 Abbott: Key Developments

Table 65 W. L. Gore & Associates, Inc.: Overview

Table 66 W. L. Gore & Associates, Inc.: Product Portfolio

Table 67 W. L. Gore & Associates, Inc.: Key Developments

Table 68 KANEKA CORPORATION: Overview

Table 69 KANEKA CORPORATION: Product Portfolio

Table 70 KANEKA CORPORATION: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Aneurysm Coiling and Embolization Devices Market Value, 2022-2031 (US$ Million)

Figure 2 Global Aneurysm Coiling and Embolization Devices Market Share, By Product, 2023 & 2031 (%)

Figure 3 Global Aneurysm Coiling and Embolization Devices Market Share, By Application, 2023 & 2031 (%)

Figure 4 Global Aneurysm Coiling and Embolization Devices Market Share, By Material, 2023 & 2031 (%)

Figure 5 Global Aneurysm Coiling and Embolization Devices Market Share, By End-user, 2023 & 2031 (%)

Figure 6 Global Aneurysm Coiling and Embolization Devices Market Share, By Region, 2023 & 2031 (%)

Figure 7 Global Aneurysm Coiling and Embolization Devices Market Y-o-Y Growth, By Product, 2023-2031 (%)

Figure 8 Embolic Coils Aneurysm Coiling and Embolization Devices Market Value, 2022-2031 (US$ Million)

Figure 9 Aneurysm clips Aneurysm Coiling and Embolization Devices Market Value, 2022-2031 (US$ Million)

Figure 10 Flow Diversion Device Aneurysm Coiling and Embolization Devices Market Value, 2022-2031 (US$ Million)

Figure 11 Liquid Embolic Agents Aneurysm Coiling and Embolization Devices Market Value, 2022-2031 (US$ Million)

Figure 12 Balloon and stent-assisted coils Aneurysm Coiling and Embolization Devices Market Value, 2022-2031 (US$ Million)

Figure 13 Others Aneurysm Coiling and Embolization Devices Market Value, 2022-2031 (US$ Million)

Figure 14 Global Aneurysm Coiling and Embolization Devices Market Y-o-Y Growth, By Application, 2023-2031 (%)

Figure 15 Tumor and Brain Cancer Application in Global Aneurysm Coiling and Embolization Devices Market Value, 2022-2031 (US$ Million)

Figure 16 Brain Arteriovenous Malformations Application in Global Aneurysm Coiling and Embolization Devices Market Value, 2022-2031 (US$ Million)

Figure 17 Ischemic Stroke Application in Global Aneurysm Coiling and Embolization Devices Market Value, 2022-2031 (US$ Million)

Figure 18 Brain Aneurysm Application in Global Aneurysm Coiling and Embolization Devices Market Value, 2022-2031 (US$ Million)

Figure 19 Cerebral Edema Application in Global Aneurysm Coiling and Embolization Devices Market Value, 2022-2031 (US$ Million)

Figure 20 Urology Application in Global Aneurysm Coiling and Embolization Devices Market Value, 2022-2031 (US$ Million)

Figure 21 Peripheral Vascular Disease Application in Global Aneurysm Coiling and Embolization Devices Market Value, 2022-2031 (US$ Million)

Figure 22 Others Application in Global Aneurysm Coiling and Embolization Devices Market Value, 2022-2031 (US$ Million)

Figure 23 Global Aneurysm Coiling and Embolization Devices Market Y-o-Y Growth, By Material, 2023-2031 (%)

Figure 24 Titanium Material in Global Aneurysm Coiling and Embolization Devices Market Value, 2022-2031 (US$ Million)

Figure 25 Cobalt Material in Global Aneurysm Coiling and Embolization Devices Market Value, 2022-2031 (US$ Million)

Figure 26 Others Material in Global Aneurysm Coiling and Embolization Devices Market Value, 2022-2031 (US$ Million)

Figure 27 Global Aneurysm Coiling and Embolization Devices Market Y-o-Y Growth, By End-user, 2023-2031 (%)

Figure 28 Hospitals End-user in Global Aneurysm Coiling and Embolization Devices Market Value, 2022-2031 (US$ Million)

Figure 29 Ambulatory Surgical Units End-user in Global Aneurysm Coiling and Embolization Devices Market Value, 2022-2031 (US$ Million)

Figure 30 Clinics End-user in Global Aneurysm Coiling and Embolization Devices Market Value, 2022-2031 (US$ Million)

Figure 31 Global Aneurysm Coiling and Embolization Devices Market Y-o-Y Growth, By Region, 2023-2031 (%)

Figure 32 North America Aneurysm Coiling and Embolization Devices Market Value, 2022-2031 (US$ Million)

Figure 33 North America Aneurysm Coiling and Embolization Devices Market Share, By Product, 2023 & 2031 (%)

Figure 34 North America Aneurysm Coiling and Embolization Devices Market Share, By Application, 2023 & 2031 (%)

Figure 35 North America Aneurysm Coiling and Embolization Devices Market Share, By Material, 2023 & 2031 (%)

Figure 36 North America Aneurysm Coiling and Embolization Devices Market Share, By End-user, 2023 & 2031 (%)

Figure 37 North America Aneurysm Coiling and Embolization Devices Market Share, By Country, 2023 & 2031 (%)

Figure 38 Asia-Pacific Aneurysm Coiling and Embolization Devices Market Value, 2022-2031 (US$ Million)

Figure 39 Asia-Pacific Aneurysm Coiling and Embolization Devices Market Share, By Product, 2023 & 2031 (%)

Figure 40 Asia-Pacific Aneurysm Coiling and Embolization Devices Market Share, By Application, 2023 & 2031 (%)

Figure 41 Asia-Pacific Aneurysm Coiling and Embolization Devices Market Share, By Material, 2023 & 2031 (%)

Figure 42 Asia-Pacific Aneurysm Coiling and Embolization Devices Market Share, By End-user, 2023 & 2031 (%)

Figure 43 Asia-Pacific Aneurysm Coiling and Embolization Devices Market Share, By Country, 2023 & 2031 (%)

Figure 44 Europe Aneurysm Coiling and Embolization Devices Market Value, 2022-2031 (US$ Million)

Figure 45 Europe Aneurysm Coiling and Embolization Devices Market Share, By Product, 2023 & 2031 (%)

Figure 46 Europe Aneurysm Coiling and Embolization Devices Market Share, By Application, 2023 & 2031 (%)

Figure 47 Europe Aneurysm Coiling and Embolization Devices Market Share, By Material, 2023 & 2031 (%)

Figure 48 Europe Aneurysm Coiling and Embolization Devices Market Share, By End-user, 2023 & 2031 (%)

Figure 49 Europe Aneurysm Coiling and Embolization Devices Market Share, By Country, 2023 & 2031 (%)

Figure 50 South America Aneurysm Coiling and Embolization Devices Market Value, 2022-2031 (US$ Million)

Figure 51 South America Aneurysm Coiling and Embolization Devices Market Share, By Product, 2023 & 2031 (%)

Figure 52 South America Aneurysm Coiling and Embolization Devices Market Share, By Application, 2023 & 2031 (%)

Figure 53 South America Aneurysm Coiling and Embolization Devices Market Share, By Material, 2023 & 2031 (%)

Figure 54 South America Aneurysm Coiling and Embolization Devices Market Share, By End-user, 2023 & 2031 (%)

Figure 55 South America Aneurysm Coiling and Embolization Devices Market Share, By Country, 2023 & 2031 (%)

Figure 56 Middle East and Africa Aneurysm Coiling and Embolization Devices Market Value, 2022-2031 (US$ Million)

Figure 57 Middle East and Africa Aneurysm Coiling and Embolization Devices Market Share, By Product, 2023 & 2031 (%)

Figure 58 Middle East and Africa Aneurysm Coiling and Embolization Devices Market Share, By Application, 2023 & 2031 (%)

Figure 59 Middle East and Africa Aneurysm Coiling and Embolization Devices Market Share, By Material, 2023 & 2031 (%)

Figure 60 Middle East and Africa Aneurysm Coiling and Embolization Devices Market Share, By End-user, 2023 & 2031 (%)

Figure 61 Acandis GmbH: Financials

Figure 62 Johnson & Johnson Services, Inc: Financials

Figure 63 Medtronic.: Financials

Figure 64 Penumbra, Inc: Financials

Figure 65 Stryker: Financials

Figure 66 Terumo Corporation: Financials

Figure 67 MicroPort Scientific Corporation: Financials

Figure 68 Abbott: Financials

Figure 69 W. L. Gore & Associates, Inc.: Financials

Figure 70 KANEKA CORPORATION: Financials

글로벌 동맥류 코일 색전술 기기 시장 – 2024-2031년

Global Aneurysm Coiling and Embolization Devices Market - 2024-2031